Authors:
Hoch, W
McConville, J
Helms, S
Newsom-Davis, J
Melms, A
Vincent, A
Citation: W. Hoch et al., Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies, NAT MED, 7(3), 2001, pp. 365-368
Citation: K. Burk et al., Effectiveness of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity, ANN NEUROL, 50(6), 2001, pp. 827-828
Authors:
Wiendl, H
Bien, CG
Bernasconi, P
Fleckenstein, B
Elger, CE
Dichgans, J
Mantegazza, R
Melms, A
Citation: H. Wiendl et al., GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis, NEUROLOGY, 57(8), 2001, pp. 1511-1514
Authors:
Buttner, U
Chofflon, M
Hess, K
Kappos, L
Kesselring, J
Ludin, HP
Schluep, M
Vaney, C
Baumhackl, U
Berger, T
Deisenhammer, F
Freimuller, M
Hartung, HP
Kollegger, H
Kristoferitsch, W
Lassmann, H
Markut, H
Vass, K
Altenkirch, H
Boese, J
Gass, A
Gehlen, W
Goebels, N
Haas, J
Haferkamp, G
Heidenreich, F
Heitmann, R
Hemmer, B
Hohlfeld, R
Janzen, RWC
Jugelt, E
Kolmel, W
Konig, N
Kowitzsch, K
Manegold, U
Melms, A
Mertin, J
Petereit, HF
Pette, M
Pohlau, D
Poser, S
Sailer, M
Schmidt, S
Schock, G
Schulz, M
Seidel, D
Stangel, M
Stark, E
Stoll, G
Weinrich, W
Wietholter, H
Zettl, UK
Zipp, F
Zschenderlein, R
Bayas, A
Chan, A
Flachenecker, P
Gold, R
Grauer, O
Jung, S
Kallmann, B
Leussink, V
Maurer, M
Rieckmann, P
Toyka, KV
Weilbach, FX
Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement, NERVENARZT, 72(2), 2001, pp. 150-157
Authors:
Bischof, F
Wienhold, W
Wirblich, C
Malcherek, G
Zevering, O
Kruisbeek, AM
Melms, A
Citation: F. Bischof et al., Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes, P NAS US, 98(21), 2001, pp. 12168-12173
Authors:
Forsthuber, TG
Shive, CL
Wienhold, W
de Graaft, K
Spack, EG
Sublett, R
Melms, A
Kort, J
Racke, MK
Weissert, R
Citation: Tg. Forsthuber et al., T cell epitopes of human myelin oligodendrocyte glycoprotein identified inHLA-DR4 (DRBI0401) transgenic mice are encephalitogenic and are presentedby human B cells, J IMMUNOL, 167(12), 2001, pp. 7119-7125
Authors:
Kalbus, M
Fleckenstein, BT
Offenhausser, M
Bluggel, M
Melms, A
Meyer, HE
Rammensee, HG
Martin, R
Jung, G
Sommer, N
Citation: M. Kalbus et al., Ligand motif of the autoimmune disease-associated mouse MHC class II molecule H2-A(S), EUR J IMMUN, 31(2), 2001, pp. 551-562
Authors:
Mader, I
Seeger, U
Weissert, R
Klose, U
Naegele, T
Melms, A
Grodd, W
Citation: I. Mader et al., Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis, BRAIN, 124, 2001, pp. 953-961
Authors:
Wienhold, W
Malcherek, G
Jung, C
Stevanovic, S
Jung, G
Schild, H
Melms, A
Citation: W. Wienhold et al., An example of immunodominance: engagement of synonymous TCR by invariant CDR3 beta, INT IMMUNOL, 12(6), 2000, pp. 747-756
Citation: C. Reinhardt et A. Melms, Normalization of elevated CD4(-)/CD8(-) (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma, ANN NEUROL, 48(4), 2000, pp. 603-608
Authors:
Herrlinger, U
Weller, M
Dichgans, J
Melms, A
Citation: U. Herrlinger et al., Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis?, ANN NEUROL, 47(5), 2000, pp. 682-683
Authors:
Herrlinger, U
Klingel, K
Meyermann, R
Kandolf, R
Kaiserling, E
Kortmann, RD
Melms, A
Skalej, M
Dichgans, J
Weller, M
Citation: U. Herrlinger et al., Central nervous system Hodgkin's lymphoma without systemic manifestation: case report and review of the literature, ACT NEUROP, 99(6), 2000, pp. 709-714
Citation: F. Bischof et al., Persistent cerebellar deterioration in a patient with lobar pneumonia under lithium, carbamazepine, and trifluperidol treatment, EUR PSYCHIA, 14(3), 1999, pp. 175-176